Association of Angiotensin Inhibitors with Improved Outcome after Acute Intracerebral Hemorrhage: Secondary Analysis of the INTERACT3 Trial
Early treatment with an angiotensin inhibitor is associated with improved outcome after ICH. Further research is needed to test for heterogeneity by ACE-I/ARB drug and treatment window to plan a clinical trial in ICH.
Authors
- Craig S. Anderson (ORCID: https://orcid.org/0000-0002-7248-4863)
- Stuart M. Allan (ORCID: https://orcid.org/0000-0001-9646-4456)
- Xinwen Ren (ORCID: https://orcid.org/0000-0002-5235-894X)
- Adrian Parry‐Jones (ORCID: https://orcid.org/0000-0002-4462-3846)
- Paul R. Kasher (ORCID: https://orcid.org/0000-0002-9213-502X)
- Xia Wang (ORCID: https://orcid.org/0000-0002-3769-1293)
Institutions
- Fudan University (CN)
- Manchester Academic Health Science Centre (GB)
- Royal Prince Alfred Hospital (AU)
- University of Manchester (GB)
- UNSW Sydney (AU)
- Shanghai Institute for Science of Science (CN)
- The George Institute for Global Health (AU)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
Publication Details
- Journal
- Cerebrovascular Diseases
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1159/000549167
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Department of Health and Social Care
- Medical Research Council
- National Health and Medical Research Council
- West China Hospital, Sichuan University